DG09--Metabolic Health & Cardiovascular Disease Risk

Thursday, October 23, 2025

7:45 AM - 9:45 AM PDT

Location: 320-322

This session topics focus on metabolic health and cardiovascular disease risk in CF population, dysglycemia in the era of highly effective modulator (HEM) therapy, GLP-1, hypertension in CF, emerging data on CVD, and overall nutrition considerations for aging related diseases

Learning Objectives:

Illustrate metabolic changes in the area of HEM with GLP-1 update
Discuss CVD risks and hypertension in CF
Review nutrition considerations for aging related disease in CF

Chair(s)

Audrey Snell, MS., RD., LD

Billings Clinic
Jessica Enders, RD, LD

Cystic Fibrosis Center of Southern Nevada

Speaker(s)

Amir Moheet, MD

University of Minnesota
LP

Lindsay Pappas, MS, RD

University of California Los Angeles
Marina Litvin, MD

Washington University School of Medicine in St. Louis
Jessica A. Alvarez, PhD, RD

Emory University School of Medicine
Agnieszka Swiatecka-Urban, MD

University of Virginia